๐ฐ Development Solutions News
Page 56 - Development Solutions News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Solutions. Real-time updates on events, politics, business and more.
April 27, 2022
IQVIA (NYSE:IQV – Get Rating) issued its quarterly earnings results on Wednesday. The medical research company reported $2.47 EPS for the quarter, topping the consensus estimate of $2.42 by $0.05, MarketWatch Earnings reports. IQVIA had a net margin of 6.96% and a return on equity of 27.51%. The firm had revenue of $3.57 billion during […]
April 22, 2022
Though a virus may not be able to discriminate, our society has in fact discriminated in the most virulent ways.
April 22, 2022
On Earth Day 2022, Auburn University is celebrating the achievement of receiving a STARS Silver Rating in recognition of its sustainability achievements from the Association for the Advancement of Sustainability in Higher Education, or AASHE.
April 19, 2022
Jhunjhunwala held 57.50 lakh shares or 3.61% stake in the firm in the last quarter against 50 lakh shares or 3.15% stake in the December quarter of the previous fiscal.
April 16, 2022
The rulers of the worldโs major military and economic powers have repeatedly claimed that they are making their nations great again.
April 9, 2022
Death rates in counties with lower incomes nearly twice that of wealthy areas
April 8, 2022
The World Happiness Report is out, and you can decide if one of the Nordic countries is worth temporarily moving to
April 8, 2022
Jackson Creek Investment Advisors LLC boosted its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 76.3% during the 4th quarter, HoldingsChannel reports. The fund owned 2,006 shares of the medical research company’s stock after buying an additional 868 shares during the quarter. Jackson Creek Investment Advisors LLC’s holdings in IQVIA were […]
April 6, 2022
Explore the latest research, expert insights, and new technology driving biopharmaceutical discovery and development
April 5, 2022
Explore the latest research, expert insights, and new technology driving biopharmaceutical discovery and development